Study Propels Biotech Company

Attention Readers: It’s Monday and our Lead Technical Tactician Nate Bear is giving you his weekly stocks to watch. This week he’s got his eyes on two tickers. Click the image below to see his latest chart setups.

If you want to know how Nate is trading one ticker for potential gains, click here to check out his newest service, Profit Surge Trader.

Good morning Wake-up Watchlisters! While you’re sipping coffee you’ll see stock futures were up on Monday. Last week the markets got off to a rough start to August, with three major gauges ending the week significantly lower in the wake of data showing continued cooling in the labor market.

The markets were down last year as well, and that gave traders the opportunity to find value stocks that actually had a chance to go up. Our Lead Fundamental Tactician Karim Rahemtulla was high on one particular stock. He’s been pounding the table on it for years now, and its seen a massive rise and there’s still time to get in.

Click here to discover “The Last Great Value Stock.”

Here’s a look at the top-moving stocks this morning.

Nektar Therapeutics (Nasdaq: NKTR)

Nektar Therapeutics is up 13.59% premarket after announcing efficacy data generated by Eli Lilly & Company for rezpegaldesleukin (REZPEG). The new data highlights the important potential of REZPEG to help patients battle a chronic skin condition known as atopic dermatitis, with the highest doses showing a mean Eczema Area and Severity Index score improvement of 83%.

Palantir Technologies (NYSE: PLTR)

Palantir Technologies is up 0.44% premarket ahead of its earnings report today. The stock rallied 135% in the three months since its last report, with chief executive officer Alex Karp talking up the power of the firm’s AI products and the demand for them.

Those are the biggest stock movers for today.

Happy trading!

The Wake-Up Watchlist Research Team

More from Wake-up Watchlist